000			01999 a2200541 4500
005			20250515160304.0
264		0	_c20090324
008			200903s 0 0 eng d
022			_a1535-7163
024	7		_a10.1158/1535-7163.MCT-08-0839 _2doi
040			_aNLM _beng _cNLM
100	1		_aGuo, Wei
245	0	0	_aInterruption of RNA processing machinery by a small compound, 1-[(4-chlorophenyl)methyl]-1H-indole-3-carboxaldehyde (oncrasin-1). _h[electronic resource]
260			_bMolecular cancer therapeutics _cFeb 2009
300			_a441-8 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650	0	4	_aCell Line, Tumor
650	0	4	_aCyclin T
650	0	4	_aCyclin-Dependent Kinase 9 _xmetabolism
650	0	4	_aCyclins _xmetabolism
650	0	4	_aDrug Screening Assays, Antitumor
650	0	4	_aGenes, Reporter
650	0	4	_aHumans
650	0	4	_aIndoles _xpharmacology
650	0	4	_aIsoenzymes _xmetabolism
650	0	4	_aLuciferases _xmetabolism
650	0	4	_aNuclear Proteins _xmetabolism
650	0	4	_aPhosphorylation _xdrug effects
650	0	4	_aPromoter Regions, Genetic
650	0	4	_aProtein Kinase C _xmetabolism
650	0	4	_aProtein Structure, Quaternary
650	0	4	_aProtein Transport _xdrug effects
650	0	4	_aRNA Polymerase II _xantagonists & inhibitors
650	0	4	_aRNA Processing, Post-Transcriptional _xdrug effects
650	0	4	_aRNA-Binding Proteins _xmetabolism
650	0	4	_aRad51 Recombinase _xmetabolism
650	0	4	_aRibonucleoproteins _xmetabolism
650	0	4	_aSerine-Arginine Splicing Factors
650	0	4	_aTranscription, Genetic _xdrug effects
700	1		_aWu, Shuhong
700	1		_aWang, Li
700	1		_aWang, Rui-yu
700	1		_aWei, Xiaoli
700	1		_aLiu, Jinsong
700	1		_aFang, Bingliang
773	0		_tMolecular cancer therapeutics _gvol. 8 _gno. 2 _gp. 441-8
856	4	0	_uhttps://doi.org/10.1158/1535-7163.MCT-08-0839 _zAvailable from publisher's website
999			_c18652522 _d18652522